Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Asset disposition Acq. announced Director departure Inv. presentation Preliminary results Quarterly results Appointed COO CC transcript
|
ATMI INC (ATMI)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/01/2014 |
8-K
| Quarterly results |
05/01/2014 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
04/23/2014 |
10-K/A
| Annual Report for the period ended December 31, 2013 [amend] |
04/15/2014 |
8-K
| Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits |
03/11/2014 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
03/11/2014 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
03/10/2014 |
SC 13G/A
| WELLS FARGO & COMPANY reports a 0% stake in ATMI INC |
03/07/2014 |
10-K
| Annual Report for the period ended December 31, 2013 |
03/06/2014 |
SC 13G/A
| ROYCE & ASSOCIATES LP reports a 2% stake in ATMI, Inc. |
02/25/2014 |
SC 13G/A
| ATMI INC reports a 5.6% stake in INTERMOLECULAR, INC. |
02/21/2014 |
8-K
| Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits |
02/20/2014 |
8-K
| Asset disposition
Docs:
|
"ATMI Completes Sale of LifeSciences Business to Pall Corporation DANBURY, CT — February 20, 2014 — ATMI, Inc. , a global technology company, announced today it has completed the sale of ATMI LifeSciences to Pall Corporation . As previously announced, the transaction includes all assets associated with the LifeSciences business. Cash proceeds from the transaction are approximately $185 million, subject to customary post-closing working capital adjustments. ATMI will report an after-tax gain during the first quarter of 2014 related to this transaction of approximately $68 million. ATMI, Inc, a global technology company, provides specialty materials, material processing, and safe, high-purity materials handling and delivery solutions designed to increase process efficiencies for the microelec..." |
|
02/14/2014 |
SC 13G
| GRANAHAN INVESTMENT MANAGEMENT INC reports a 5.9% stake in ATMI, Inc. |
02/13/2014 |
SC 13D
| GAMCO INVESTORS, INC. ET AL reports a 3.8% stake in ATMI, Inc. |
02/12/2014 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
02/11/2014 |
SC 13G/A
| VANGUARD GROUP INC reports a 6.3% stake in ATMI Inc |
02/07/2014 |
SC 13G/A
| PRUDENTIAL FINANCIAL INC has filed a Schedule 13D for ATMI INC |
02/07/2014 |
SC 13G/A
| WESTFIELD CAPITAL MANAGEMENT CO LP reports a 0% stake in ATMI Inc |
02/06/2014 |
SC 13G/A
| JENNISON ASSOCIATES LLC reports a 2.3% stake in ATMI, Inc. |
02/04/2014 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
02/04/2014 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
02/04/2014 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
02/04/2014 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
02/04/2014 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
02/04/2014 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
02/04/2014 |
8-K
| Quarterly results
Docs:
|
"ATMI REPORTS FINANCIAL RESULTS FOR THE FOURTH QUARTER OF 2013 Revenues grew 6 percent compared with last year to $94.8 million Income from continuing operations was $0.19 per diluted share Income includes asset impairment charge of $0.28 per diluted share and a gain of $0.03 per diluted share DANBURY, CT — February 4, 2014 — ATMI, Inc. , a global technology company, today reported financial results for the fourth quarter of 2013. Revenues from continuing operations were $94.8 million during the fourth quarter of 2013, an increase of 6 percent compared with $89.2 million during the same period last year, lifted by strong demand for products in Microelectronics, especially implant, and eVOLV™ license revenues. Income from continuing operations was $6.4 million, or $0.19 per diluted sha...",
"Presentation by ATMI, Inc." |
|
02/04/2014 |
8-K
| Acquisition/merger/asset purchase announced |
02/04/2014 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
01/28/2014 |
SC 13G/A
| WELLS FARGO & COMPANY reports a 7% stake in ATMI INC |
01/28/2014 |
SC 13G/A
| BlackRock Inc. reports a 8.8% stake in ATMI INC. |
01/06/2014 |
SC 13G/A
| ROYCE & ASSOCIATES LP reports a 8.9% stake in ATMI, Inc. |
12/23/2013 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs:
|
"Share and Asset Purchase Agreement, by and among ATMI, Inc., ATMI Packaging, Inc., Advanced Technology Materials, Inc., ATMI SARL, ATMI Belgium LLC, and Pall Corporation",
"(PRESS RELEASE)" |
|
11/01/2013 |
8-K
| Form 8-K - Current report |
10/23/2013 |
10-Q
| Quarterly Report for the period ended September 30, 2013 |
|
|
|